share_log

BRIEF-MYND Life Sciences Signs Deal To Buy Rights For Use Of Psychedelics To Treat Alzheimer's Disease

BRIEF-MYND Life Sciences Signs Deal To Buy Rights For Use Of Psychedelics To Treat Alzheimer's Disease

Brief-mynd生命科学公司签署协议购买使用迷幻药治疗阿尔茨海默病的权利
reuters ·  2021/10/27 08:22

Oct 27 (Reuters) - MYND Life Sciences Inc MYND.CD :

路透10月27日电-Mynd Life Science Inc MYND.CD:

* MYND LIFE SCIENCES SIGNS AGREEMENT TO ACQUIRE RIGHTS FOR THE USE OF PSYCHEDELICS TO TREAT ALZHEIMER'S DISEASE AND OTHER DEMENTIAS

*Mynd生命科学签署协议,获得使用迷幻剂治疗阿尔茨海默病和其他痴呆症的权利

Source text for Eikon: ID:nCNW3R7hJa Further company coverage: MYND.CD

Eikon的源文本:ID:nCNW3R7hJa进一步的公司报道:MYND.CD

((Reuters.Briefs@thomsonreuters.com;))

(Reurs.Briefs@thomsonreurs.com;)

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发